Agonist: Difference between revisions

From The School of Biomedical Sciences Wiki
Jump to navigation Jump to search
Nnjm2 (talk | contribs)
No edit summary
160043891 (talk | contribs)
Rewritten the whole page in order to grant a more comprehensive view of the theoretical aspects and applied them to various scenarios, reinforcing the theory.
Line 1: Line 1:
An agonist is a ligand ([[Molecule|molecules]] that bind other molecules) that can be a drug or an [[Endogenous|endogenous molecule]] that bind to a receptor and elicit a cellular response, usually a [[Signalling|signalling pathway]]. An example of an endogenous molecule that would be an agonist could be a [[Neurotransmitter|neurotransmitter]] or a [[Hormone|hormone]], such as [[Estradiol|estradiol]] <ref>Berg et al., (2006) Biochemistry, 6th edition, New York, Pg 910</ref>&nbsp;.  
An agonist is a ligand capable of binding to a receptor as a result of it's affinity to the given molecule, and causing a conformational change which stabilises the receptor in an activated conformation. The affinity of the ligand to the receptor is determined through molecular forces such as (in order of least to greatest strength) Vaan Der Vaals forces, ionic bonds, hydrogen bonds and covalent bonds. The presence of the receptor in an activated conformation allows for (mainly) cytoplasmic protein interaction and transmission of the signal into the cell, and an associated response e.g. increased gene expression.&nbsp;
 
In terms of administration, agonists can be exogenous or endogenous molecules. The most common exogenous agonists that enter our body are actually unwanted, in contrast to desired administration of exogenous agonists e.g. medicines like morphine. Unwanted exogenous agonists can include chemicals produced in the work place, food additives, gaseous chemicals produced through pollution, second-hand smoke etc. Desired administration of exogenous agonists has many uses. Most common amongst these are pleasure (e.g. from ethanol), therapeutic effects (e.g. from aspirin) or religious experiences (e.g. entheogens).&nbsp;
 
Endogenous agonists are molecules, typically synthesized or modified using metabolic pathways, present without prior administration. This does not mean however, that their quantity in the body is not alterable. For example, different levels of precursors to the final, endogenous agonists affect the level of the ligand. L-Dopa, a principal treatment for Parkinson's disease, is used in this way as it increases the levels of endogenous dopamine in the substantia nigra of affected patients. The level of gene expression is also important as it determines the quantity of enzymes capable of creating the final endogenous agonist. A greater amount of enzyme will increase the speed of synthesis of the final agonist, and thus increase it's effects.&nbsp;
 
 
 
([[Molecule|molecule]]&nbsp;that bind other molecules) that can be a drug or an [[Endogenous|endogenous molecule]] that binds to a receptor and elicit a cellular response, usually a [[Signalling|signalling pathway]]. An example of an endogenous molecule that would be an agonist could be a [[Neurotransmitter|neurotransmitter]] or a [[Hormone|hormone]], such as [[Estradiol|estradiol]] <ref>Berg et al., (2006) Biochemistry, 6th edition, New York, Pg 910</ref>&nbsp;.  


Another example of an agonist is [[Nicotine|nicotine]]. Nicotine is a natural compound and is the chemical that is found in tobacco. [[Nicotine|Nicotine]] acts as an [[Antagonist|antagonist]] by binding to the same receptor as the main excitatory neurotransmitter [[Acetylcholine|acetylcholine]] and mimics the action of this [[Neurotransmitter|neurotransmitter]], therefore eliciting a cellular response <ref>Silverthorn et al., (2009) Human Physiology: An Integrated Approach, 5th Edition, San Francisco, Pg 41</ref>.  
Another example of an agonist is [[Nicotine|nicotine]]. Nicotine is a natural compound and is the chemical that is found in tobacco. [[Nicotine|Nicotine]] acts as an [[Antagonist|antagonist]] by binding to the same receptor as the main excitatory neurotransmitter [[Acetylcholine|acetylcholine]] and mimics the action of this [[Neurotransmitter|neurotransmitter]], therefore eliciting a cellular response <ref>Silverthorn et al., (2009) Human Physiology: An Integrated Approach, 5th Edition, San Francisco, Pg 41</ref>.  
Line 5: Line 13:
A partial agonist is a compound that binds to a receptor producing an incomplete response, therefore it is considered to be less [[Potent|potent]].  
A partial agonist is a compound that binds to a receptor producing an incomplete response, therefore it is considered to be less [[Potent|potent]].  


The opposite of an agonist is an [[Antagonist|antagonist]]
The opposite of an agonist is an [[Antagonist|antagonist]]  


=== References  ===
=== References  ===


<references />
<references />

Revision as of 11:51, 24 October 2017

An agonist is a ligand capable of binding to a receptor as a result of it's affinity to the given molecule, and causing a conformational change which stabilises the receptor in an activated conformation. The affinity of the ligand to the receptor is determined through molecular forces such as (in order of least to greatest strength) Vaan Der Vaals forces, ionic bonds, hydrogen bonds and covalent bonds. The presence of the receptor in an activated conformation allows for (mainly) cytoplasmic protein interaction and transmission of the signal into the cell, and an associated response e.g. increased gene expression. 

In terms of administration, agonists can be exogenous or endogenous molecules. The most common exogenous agonists that enter our body are actually unwanted, in contrast to desired administration of exogenous agonists e.g. medicines like morphine. Unwanted exogenous agonists can include chemicals produced in the work place, food additives, gaseous chemicals produced through pollution, second-hand smoke etc. Desired administration of exogenous agonists has many uses. Most common amongst these are pleasure (e.g. from ethanol), therapeutic effects (e.g. from aspirin) or religious experiences (e.g. entheogens). 

Endogenous agonists are molecules, typically synthesized or modified using metabolic pathways, present without prior administration. This does not mean however, that their quantity in the body is not alterable. For example, different levels of precursors to the final, endogenous agonists affect the level of the ligand. L-Dopa, a principal treatment for Parkinson's disease, is used in this way as it increases the levels of endogenous dopamine in the substantia nigra of affected patients. The level of gene expression is also important as it determines the quantity of enzymes capable of creating the final endogenous agonist. A greater amount of enzyme will increase the speed of synthesis of the final agonist, and thus increase it's effects. 


(molecule that bind other molecules) that can be a drug or an endogenous molecule that binds to a receptor and elicit a cellular response, usually a signalling pathway. An example of an endogenous molecule that would be an agonist could be a neurotransmitter or a hormone, such as estradiol [1] .

Another example of an agonist is nicotine. Nicotine is a natural compound and is the chemical that is found in tobacco. Nicotine acts as an antagonist by binding to the same receptor as the main excitatory neurotransmitter acetylcholine and mimics the action of this neurotransmitter, therefore eliciting a cellular response [2].

A partial agonist is a compound that binds to a receptor producing an incomplete response, therefore it is considered to be less potent.

The opposite of an agonist is an antagonist

References

  1. Berg et al., (2006) Biochemistry, 6th edition, New York, Pg 910
  2. Silverthorn et al., (2009) Human Physiology: An Integrated Approach, 5th Edition, San Francisco, Pg 41